医療用インプラントの世界市場予測(~2027年)

• 英文タイトル:Medical Implants Market Research Report by Type, Type of Material, End-User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

Medical Implants Market Research Report by Type, Type of Material, End-User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19「医療用インプラントの世界市場予測(~2027年)」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2301B169
• 出版社/出版日:360iResearch / 2022年10月
• レポート形態:英語、PDF、238ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥742,350 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,492,350 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
360iリサーチ社の本調査資料では、2021年に784.2億ドルであった医療用インプラントの世界市場規模が、2022年に848.2億ドルになり、2027年には1,268.0億ドルまで、年平均8.33%で拡大すると予測しています。本資料では、世界の医療用インプラント市場について調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、種類別(心臓インプラント、美容インプラント、歯科インプラント、眼科用インプラント、その他)分析、材料種類別(セラミック材料、金属材料、ポリマー材料)分析、エンドユーザー別(病院&クリニック、研究所)分析、地域別(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)分析、競争状況などを掲載しています。また、本書の企業情報には、3M、Allergan, Inc.、Boston Scientific、C2F Implants、CARDINAL HEALTH, INC.、Ceraver、CONMED Corporation、Dentsply、DIO Corporation、Edwards Lifesciences、GC Aesthetics PLC、GLOBUS MEDICAL, INC.、Hipokrat A.S、Johnson & Johnson Services, Inc、LIVANOVA PLC、Medtronic、Neovasc Inc.、Shofu Dental Corporation、Sientra、Smith & Nephew、Spectrum Designs Medical、Straumann、Stryker Corporation、Waldemar Link GmbH & Co. KG、Young Innovations, Inc.、Zimmer Biometなどがあります。
・序論
・調査方法
・エグゼクティブサマリー
・市場概要
・市場インサイト
・世界の医療用インプラント市場規模:種類別
- 心臓インプラントの市場規模
- 美容インプラントの市場規模
- 歯科インプラントの市場規模
- 眼科用インプラントの市場規模
- その他種類の市場規模
・世界の医療用インプラント市場規模:材料種類別
- セラミックインプラントの市場規模
- 金属インプラントの市場規模
- ポリマーインプラントの市場規模
・世界の医療用インプラント市場規模:エンドユーザー別
- 病院&クリニックにおける市場規模
- 研究所における市場規模
・世界の医療用インプラント市場規模:地域別
- 南北アメリカの医療用インプラント市場規模
アメリカの医療用インプラント市場規模
カナダの医療用インプラント市場規模
ブラジルの医療用インプラント市場規模
...
- アジア太平洋の医療用インプラント市場規模
日本の医療用インプラント市場規模
中国の医療用インプラント市場規模
インドの医療用インプラント市場規模
韓国の医療用インプラント市場規模
台湾の医療用インプラント市場規模
...
- ヨーロッパ/中東/アフリカの医療用インプラント市場規模
イギリスの医療用インプラント市場規模
ドイツの医療用インプラント市場規模
インドの医療用インプラント市場規模
フランスの医療用インプラント市場規模
ロシアの医療用インプラント市場規模
...
- その他地域の医療用インプラント市場規模

・競争状況
・企業情報

The Global Medical Implants Market size was estimated at USD 78.42 billion in 2021 and expected to reach USD 84.82 billion in 2022, and is projected to grow at a CAGR 8.33% to reach USD 126.80 billion by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Medical Implants to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the market was studied across Cardiac Implants, Cosmetic Implants, Dental Implants, Ophthalmic Implants, Orthopedic Implants, and Spinal Implants.

Based on Type of Material, the market was studied across Ceramic Material, Metallic Material, and Polymers Material.

Based on End-User, the market was studied across Hospitals & Clinics and Research Laboratories.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Medical Implants market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Medical Implants Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Medical Implants Market, including 3M, Allergan, Inc., Boston Scientific, C2F Implants, CARDINAL HEALTH, INC., Ceraver, CONMED Corporation, Dentsply, DIO Corporation, Edwards Lifesciences, GC Aesthetics PLC, GLOBUS MEDICAL, INC., Hipokrat A.S, Johnson & Johnson Services, Inc, LIVANOVA PLC, Medtronic, Neovasc Inc., Shofu Dental Corporation, Sientra, Smith & Nephew, Spectrum Designs Medical, Straumann, Stryker Corporation, Waldemar Link GmbH & Co. KG, Young Innovations, Inc., and Zimmer Biomet.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Medical Implants Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Medical Implants Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Medical Implants Market?
4. What is the competitive strategic window for opportunities in the Global Medical Implants Market?
5. What are the technology trends and regulatory frameworks in the Global Medical Implants Market?
6. What is the market share of the leading vendors in the Global Medical Implants Market?
7. What modes and strategic moves are considered suitable for entering the Global Medical Implants Market?

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising elderly population and increasing prevalence rate of chronic diseases
5.1.1.2. Increasing demand for cosmetic dentistry
5.1.1.3. Development of smart cardiovascular implants
5.1.2. Restraints
5.1.2.1. High cost of treatment associated with medical implant
5.1.3. Opportunities
5.1.3.1. Emerging development of implants in the medical technology with biopolymers and biomaterials
5.1.3.2. Application of 3D printing in implantable medical devices
5.1.4. Challenges
5.1.4.1. Complicated implant design
5.2. Cumulative Impact of COVID-19

6. Medical Implants Market, by Type
6.1. Introduction
6.2. Cardiac Implants
6.3. Cosmetic Implants
6.4. Dental Implants
6.5. Ophthalmic Implants
6.6. Orthopedic Implants
6.7. Spinal Implants

7. Medical Implants Market, by Type of Material
7.1. Introduction
7.2. Ceramic Material
7.3. Metallic Material
7.4. Polymers Material

8. Medical Implants Market, by End-User
8.1. Introduction
8.2. Hospitals & Clinics
8.3. Research Laboratories

9. Americas Medical Implants Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Medical Implants Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Medical Implants Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. 3M
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Allergan, Inc.
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Boston Scientific
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. C2F Implants
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. CARDINAL HEALTH, INC.
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Ceraver
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. CONMED Corporation
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Dentsply
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. DIO Corporation
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Edwards Lifesciences
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. GC Aesthetics PLC
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. GLOBUS MEDICAL, INC.
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Hipokrat A.S
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Johnson & Johnson Services, Inc
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. LIVANOVA PLC
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Medtronic
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Neovasc Inc.
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Shofu Dental Corporation
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Sientra
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Smith & Nephew
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. Spectrum Designs Medical
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
13.22. Straumann
13.22.1. Business Overview
13.22.2. Key Executives
13.22.3. Product & Services
13.23. Stryker Corporation
13.23.1. Business Overview
13.23.2. Key Executives
13.23.3. Product & Services
13.24. Waldemar Link GmbH & Co. KG
13.24.1. Business Overview
13.24.2. Key Executives
13.24.3. Product & Services
13.25. Young Innovations, Inc.
13.25.1. Business Overview
13.25.2. Key Executives
13.25.3. Product & Services
13.26. Zimmer Biomet
13.26.1. Business Overview
13.26.2. Key Executives
13.26.3. Product & Services

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing




• 英文レポート名:Medical Implants Market Research Report by Type, Type of Material, End-User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
• 日本語訳:医療用インプラントの世界市場予測(~2027年)
• レポートコード:MRC2301B169お問い合わせ(見積依頼・ご注文・質問)